SCHEMBL702189

SCHEMBL702189

Oc1ccccc1-c1c2ccccc2c(-c2ccccc2O)c2ccccc12

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 5/20 0.52
ALDH1A1 P00352 4/20 0.52
HSD17B10 Q99714 4/20 0.52
BCL2L1 Q07817 1/20 0.52
IDO1 P14902 6/20 0.48
MAPT P10636 5/20 0.47
SMN1; SMN2 Q16637 3/20 0.47
KDM4E B2RXH2 3/20 0.47
RECQL P46063 3/20 0.47
ALOX15 P16050 3/20 0.47
TDP1 Q9NUW8 3/20 0.47
NPC1 O15118 2/20 0.47
POLB P06746 2/20 0.47
RAB9A P51151 2/20 0.47
LMNA P02545 2/20 0.47
CA12 O43570 1/20 0.47
GMNN O75496 1/20 0.47
EGFR P00533 1/20 0.47
CA2 P00918 1/20 0.47
FYN P06241 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7176241 0.84 ALOX5 (0.55) HPGDALDH1A1HSD17B10BCL2L1MAPT
SCHEMBL31145083 0.84 ALOX5 (0.55) HPGDALDH1A1HSD17B10BCL2L1MAPT
SCHEMBL9973582 0.82 HPGD (0.50) HPGDALDH1A1HSD17B10BCL2L1IDO1
SCHEMBL12600799 0.82 MAOA (0.42) HPGDALDH1A1HSD17B10BCL2L1MAPT
SCHEMBL30397720 0.80 ALDH1A1 (0.55) HPGDALDH1A1HSD17B10BCL2L1IDO1
SCHEMBL29837181 0.80 MAOA (0.56) HPGDALDH1A1HSD17B10BCL2L1IDO1
SCHEMBL1980808 0.80 ALDH1A1 (0.55) HPGDALDH1A1HSD17B10BCL2L1IDO1
SCHEMBL2729251 0.80 MAOA (0.56) HPGDALDH1A1HSD17B10BCL2L1IDO1
SCHEMBL29623192 0.78 ALDH1A1 (0.67) HPGDALDH1A1HSD17B10BCL2L1IDO1
SCHEMBL28574 0.78 ALDH1A1 (0.67) HPGDALDH1A1HSD17B10BCL2L1IDO1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1859005-B1 NOVEL MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2016-04-27 EP disclosed
EP-1859005-B1 NOVEL MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2016-04-27 EP disclosed
US-8124249-B2 Derivatives of fused aromatic systems; stability; sublimation stability; easy to purify due to better solubilty; easy reproducibility because do not form isomers MERCK PATENT GMBH (DE) 2012-02-28 US disclosed
US-8124249-B2 Derivatives of fused aromatic systems; stability; sublimation stability; easy to purify due to better solubilty; easy reproducibility because do not form isomers MERCK PATENT GMBH (DE) 2012-02-28 US disclosed
US-8124249-B2 Derivatives of fused aromatic systems; stability; sublimation stability; easy to purify due to better solubilty; easy reproducibility because do not form isomers MERCK PATENT GMBH (DE) 2012-02-28 US disclosed
US-20080171225-A1 Novel Materials For Organic Electroluminescent Devices MERCK PATENT GMBH (DE) 2008-07-17 US disclosed
US-20080171225-A1 Novel Materials For Organic Electroluminescent Devices MERCK PATENT GMBH (DE) 2008-07-17 US disclosed
US-20080171225-A1 Novel Materials For Organic Electroluminescent Devices MERCK PATENT GMBH (DE) 2008-07-17 US disclosed
EP-1859005-A1 NOVEL MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES Merck Patent GmbH (DE) 2007-11-28 EP disclosed
WO-2006097208-A1 NOVEL MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2006-09-21 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080171225-A1 Novel Materials For Organic Electroluminescent Devices OR10J3, EML4, TYR HPGD 3418/4885ALDH1A1 1325/4885HSD17B10 3627/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.